MENU

PIVOT: PAM-independent TIGR-Tas editor for AAV and LNP delivery

Research Square
Overview
Researchers have developed PIVOT, a hyper-compact, PAM-independent genome editor that achieves editing activity comparable to SpRY in mammalian cells. The system enables durable hepatic PCSK9 knockout via a single AAV vector and supports LNP delivery through a circularized tigRNA called Mobius.
In Depth

Key Findings

The PIVOT (PAM-Independent Versatile and Optimized TIGR-Tas) editor demonstrates high specificity and editing activity in mammalian cells comparable to SpRY. In vivo applications using a single AAV vector resulted in durable hepatic PCSK9 knockout, which reduced circulating PCSK9 by ~82% and serum LDL-C by ~47%. Additionally, microinjection into mouse zygotes enabled efficient germline editing.

Technical Details

PIVOT was developed through iterative engineering based on deep mutational scanning of the TIGR-ParTasR nuclease and its cognate tigRNA. This process identified that intrinsic tigRNA instability and weak protein-nucleic acid contacts were the primary constraints on editing activity. To further enhance the system for lipid-nanoparticle (LNP) delivery, a covalently circularized tigRNA named Mobius was created to improve RNA stability. This PIVOT/Mobius combination provides a compact editor compatible with both LNP- and AAV-mediated delivery methods.

Background & Context

Therapeutic RNA-guided genome editors typically require a combination of broad genomic access and efficient delivery, but these two properties are rarely found together in existing nucleases. While tandem interspaced guide RNA (TIGR)-Tas systems are compact and PAM-independent, their editing activity has historically remained low, necessitating the optimizations that led to PIVOT.

Significance & Outlook

The development of PIVOT addresses the critical trade-off between nuclease size and genomic accessibility. By eliminating PAM dependence and reducing the system’s footprint, PIVOT allows for the use of single AAV vectors for in vivo editing. The integration of the Mobius circularized tigRNA further expands the delivery toolkit to include LNPs, offering a versatile platform for targeting various genomic sites with high efficiency and specificity.

Source: https://doi.org/10.21203/rs.3.rs-11118113/v1

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Published by Troy-Technical, an independent site run by one engineer with a career in materials development.
About the author / Contact info@troy-technical.jp
Let's share this post !

Author of this article

TOC